This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
6lnr
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Structure of intact chitinase with hevein domain from the plant Simarouba glauca, known for its traditional anti-inflammatory efficacy== | |
| - | + | <StructureSection load='6lnr' size='340' side='right'caption='[[6lnr]]' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6LNR OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=6LNR FirstGlance]. <br> | |
| - | + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6lnr FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6lnr OCA], [http://pdbe.org/6lnr PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6lnr RCSB], [http://www.ebi.ac.uk/pdbsum/6lnr PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6lnr ProSAT]</span></td></tr> | |
| - | [[ | + | </table> |
| - | [[ | + | __TOC__ |
| - | [[Category: Ankur | + | </StructureSection> |
| - | [[Category: Gunasekaran | + | [[Category: Large Structures]] |
| - | [[Category: | + | [[Category: Ankur T]] |
| - | [[Category: Ramya | + | [[Category: Gunasekaran K]] |
| + | [[Category: KanalElamparithi B]] | ||
| + | [[Category: Radha A]] | ||
| + | [[Category: Ramya KS]] | ||
Revision as of 10:27, 24 December 2020
Structure of intact chitinase with hevein domain from the plant Simarouba glauca, known for its traditional anti-inflammatory efficacy
| |||||||||||
